SFCM
PRAX icon

Seven Fleet Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Seven Fleet Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
+7,540
New +$2.39M 0.42% 38
2026
Q1 		– Sell
-2,700
Closed -$796K – 131
2025
Q4 		$796K Buy
+2,700
New +$503K 0.54% 35

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Seven Fleet Capital Management's PRAX Position: Q2 2026 in Review

Seven Fleet Capital Management opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 7,540 shares worth $2.52M. The stake represents 0.42% of the portfolio and ranks #38 among its holdings. This is a return to the name: Seven Fleet Capital Management previously reported a position in PRAX as recently as Q4 2025.

Seven Fleet Capital Management first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Seven Fleet Capital Management held 7,540 shares of Praxis Precision Medicines worth $2.52M as of Q2 2026.
  • Praxis Precision Medicines was a new Seven Fleet Capital Management position in Q2 2026.
  • Praxis Precision Medicines made up 0.42% of Seven Fleet Capital Management's portfolio in Q2 2026, its #38 holding.
  • Seven Fleet Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.